Brief: CMS Publish Negative Proposed Ncd For Epi Procolon
16/10/2020 23:08
Oct 16 (Reuters) - Epigenomics AG ECXn.DE :
* : U.S. CENTERS FOR MEDICARE & MEDICAID SERVICES PUBLISH
NEGATIVE
PROPOSED NCD FOR EPI PROCOLON
* PROPOSED NCD IS PRELIMINARY
* CMS WILL PUBLISH THEIR FINAL DECISION WITHIN 60 DAYS
* IF FINAL DECISION IS ALSO NEGATIVE, COMPANY WILL TAKE
OPPORTUNITY TO APPEAL DECISION
Source text for Eikon: ID:nEQ7lhYDfa
Further company coverage: ECXn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns